Skip to content

Drug interactions

Danicopan + Idarubicin

Severity: Moderate

Danicopan and Idarubicin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Danicopan inhibits P-glycoprotein and may increase idarubicin concentrations, raising the risk of myelosuppression and cardiotoxicity. Complement inhibition also adds infection risk in neutropenic patients.

What this interaction means in plain words

Danicopan and Idarubicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Danicopan belongs to Miscellaneous; Idarubicin belongs to Oncology.

Evidence level: Low

Why it happens

P-gp inhibition by danicopan decreases idarubicin efflux.

What to do

Monitor blood counts and cardiac function, and consider reducing the idarubicin dose if toxicity appears.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Danicopan and Idarubicin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Danicopan with Idarubicin?

MediHelp rates the interaction as moderate. Danicopan and Idarubicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Danicopan inhibits P-glycoprotein and may increase idarubicin concentrations, raising the risk of myelosuppression and cardiotoxicity. Complement inhibition also adds infection risk in neutropenic patients.

How serious is the interaction between Danicopan and Idarubicin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac function, and consider reducing the idarubicin dose if toxicity appears.

What other medicines interact with Idarubicin?

MediHelp also lists interactions of Idarubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclophosphamide. The full list is on the Idarubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in